What is the expected outcome for an adult patient taking daily aspirin for stroke risk management?

What is the expected outcome for an adult patient taking daily aspirin for stroke risk management?

• A. Reduction in risk of stroke
• B. Increased risk of gastrointestinal bleeding
• C. Decreased bone density
• D. Altered liver function

Answer: (A)

The expected outcome for an adult patient taking daily aspirin for stroke risk management is a reduction in the risk of stroke. Aspirin works as an antiplatelet agent, meaning it helps to prevent the formation of blood clots by inhibiting platelet aggregation. This is particularly important in individuals who are at risk for ischemic strokes, as these types of strokes are typically caused by blood clots blocking blood flow to the brain. By reducing the likelihood of clots forming, daily aspirin therapy can significantly lower the chances of experiencing a stroke-related event. While there are potential side effects associated with long-term aspirin use—such as an increased risk of gastrointestinal bleeding—the primary benefit in terms of stroke prevention is the reduction in associated risk factors, making it a valuable therapeutic intervention for appropriate patients. Additionally, the effects on bone density and liver function are not typically direct outcomes of aspirin use in the context of stroke prevention, hence they do not apply as expected outcomes in this situation.

The expected outcome for an adult patient taking daily aspirin for stroke risk management is a reduction in the risk of stroke. Aspirin works as an antiplatelet agent, meaning it helps to prevent the formation of blood clots by inhibiting platelet aggregation. This is particularly important in individuals who are at risk for ischemic strokes, as these types of strokes are typically caused by blood clots blocking blood flow to the brain. By reducing the likelihood of clots forming, daily aspirin therapy can significantly lower the chances of experiencing a stroke-related event.

While there are potential side effects associated with long-term aspirin use—such as an increased risk of gastrointestinal bleeding—the primary benefit in terms of stroke prevention is the reduction in associated risk factors, making it a valuable therapeutic intervention for appropriate patients. Additionally, the effects on bone density and liver function are not typically direct outcomes of aspirin use in the context of stroke prevention, hence they do not apply as expected outcomes in this situation.